164 related articles for article (PubMed ID: 21443749)
1. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
4. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
[TBL] [Abstract][Full Text] [Related]
5. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
[TBL] [Abstract][Full Text] [Related]
6. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
7. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
Sainz-Perez A; Gary-Gouy H; Gaudin F; Maarof G; Marfaing-Koka A; de Revel T; Dalloul A
J Immunol; 2008 Nov; 181(9):6051-60. PubMed ID: 18941194
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the expression of CD32 and CD180 receptors on CLL cells and MEC1 cell line.
Tsertsvadze T; Mitskevich N; Ghirdaladze D; Porakishvili N
Georgian Med News; 2015 Mar; (240):56-9. PubMed ID: 25879560
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
[TBL] [Abstract][Full Text] [Related]
10. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
[TBL] [Abstract][Full Text] [Related]
11. Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.
Porakishvili N; Vispute K; Steele AJ; Rajakaruna N; Kulikova N; Tsertsvadze T; Nathwani A; Damle RN; Clark EA; Rai KR; Chiorazzi N; Lydyard PM
Mol Med; 2015 Apr; 21(1):46-57. PubMed ID: 25611435
[TBL] [Abstract][Full Text] [Related]
12. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
13. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
[TBL] [Abstract][Full Text] [Related]
16. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Söderberg O; Christiansen I; Carlsson M; Nilsson K
Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
[TBL] [Abstract][Full Text] [Related]
18. Release of clonal block in B cell chronic lymphocytic leukaemia by engagement of co-operative epitopes on CD40.
Jacob A; Pound JD; Challa A; Gordon J
Leuk Res; 1998 Apr; 22(4):379-82. PubMed ID: 9669843
[TBL] [Abstract][Full Text] [Related]
19. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
[TBL] [Abstract][Full Text] [Related]
20. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]